Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 281

1.

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Porteous MK, Lee JC, Lederer DJ, Palmer SM, Cantu E, Shah RJ, Bellamy SL, Lama VN, Bhorade SM, Crespo MM, McDyer JF, Wille KM, Localio AR, Orens JB, Shah PD, Weinacker AB, Arcasoy S, Wilkes DS, Ware LB, Christie JD, Kawut SM, Diamond JM; Lung Transplant Outcomes Group.

Ann Am Thorac Soc. 2017 Jul 18. doi: 10.1513/AnnalsATS.201610-810OC. [Epub ahead of print]

PMID:
28719755
2.

Danger signals in regulating the immune response to solid organ transplantation.

Todd JL, Palmer SM.

J Clin Invest. 2017 Jun 30;127(7):2464-2472. doi: 10.1172/JCI90594. Epub 2017 May 22.

3.

The Diacetyl-Exposed Human Airway Epithelial Secretome: New Insights into Flavoring-Induced Airways Disease.

Brass DM, Gwinn WM, Valente AM, Kelly FL, Brinkley CD, Nagler AE, Moseley MA, Morgan DL, Palmer SM, Foster MW.

Am J Respir Cell Mol Biol. 2017 Jun;56(6):784-795. doi: 10.1165/rcmb.2016-0372OC.

PMID:
28248570
4.

Models of toxicity of diacetyl and alternative diones.

Brass DM, Palmer SM.

Toxicology. 2017 Feb 21. pii: S0300-483X(17)30057-4. doi: 10.1016/j.tox.2017.02.011. [Epub ahead of print]

PMID:
28232124
5.

Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction.

Weigt SS, Wang X, Palchevskiy V, Gregson AL, Patel N, DerHovanessian A, Shino MY, Sayah DM, Birjandi S, Lynch JP 3rd, Saggar R, Ardehali A, Ross DJ, Palmer SM, Elashoff D, Belperio JA.

PLoS One. 2017 Jan 19;12(1):e0169894. doi: 10.1371/journal.pone.0169894. eCollection 2017.

6.

An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.

Petrovski S, Todd JL, Durheim MT, Wang Q, Chien JW, Kelly FL, Frankel C, Mebane CM, Ren Z, Bridgers J, Urban TJ, Malone CD, Finlen Copeland A, Brinkley C, Allen AS, O'Riordan T, McHutchison JG, Palmer SM, Goldstein DB.

Am J Respir Crit Care Med. 2017 Jul 1;196(1):82-93. doi: 10.1164/rccm.201610-2088OC.

PMID:
28099038
7.

Moorland vegetation burning debates should avoid contextomy and anachronism: a comment on Davies et al. (2016).

Brown LE, Holden J, Palmer SM.

Philos Trans R Soc Lond B Biol Sci. 2016 Nov 19;371(1708). pii: 20160432. doi: 10.1098/rstb.2016.0432. Epub 2016 Oct 10. No abstract available.

8.

Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?

Vacha M, Chery G, Hulbert A, Byrns J, Benedetti C, Finlen Copeland CA, Gray A, Onwuemene O, Palmer SM, Snyder LD.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12886. Epub 2017 Feb 1.

PMID:
27988971
9.

Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl.

Foster MW, Gwinn WM, Kelly FL, Brass DM, Valente AM, Moseley MA, Thompson JW, Morgan DL, Palmer SM.

J Proteome Res. 2017 Feb 3;16(2):538-549. doi: 10.1021/acs.jproteome.6b00672. Epub 2017 Jan 9.

PMID:
27966365
10.

Depressive symptoms and early mortality following lung transplantation: A pilot study.

Smith PJ, Blumenthal JA, Snyder LD, Mathew JP, Durheim MT, Hoffman BM, Rivelli SK, Palmer SM.

Clin Transplant. 2017 Feb;31(2). doi: 10.1111/ctr.12874. Epub 2016 Dec 23.

PMID:
27859626
11.

Deployment of the 1st Area Medical Laboratory in a Split-Based Configuration During the Largest Ebola Outbreak in History.

Cardile AP, Littell CT, Backlund MG, Heipertz RA, Brammer JA, Palmer SM, Vento TJ, Ortiz FA, Rosa WR, Major MJ, Garman PM.

Mil Med. 2016 Nov;181(11):e1675-e1684.

PMID:
27849507
12.

High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JH, Basner RC, Bartels MN, Christie JD, Enright PL, Gochuico BR, Hinckley Stukovsky K, Kaufman JD, Hrudaya Nath P, Newell JD Jr, Palmer SM, Rabinowitz D, Raghu G, Sell JL, Sieren J, Sonavane SK, Tracy RP, Watts JR, Williams K, Kawut SM, Lederer DJ.

Eur Respir J. 2016 Nov;48(5):1442-1452. doi: 10.1183/13993003.00129-2016. Epub 2016 Jul 28.

PMID:
27471206
13.

Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity.

Hubbs AF, Fluharty KL, Edwards RJ, Barnabei JL, Grantham JT, Palmer SM, Kelly F, Sargent LM, Reynolds SH, Mercer RR, Goravanahally MP, Kashon ML, Honaker JC, Jackson MC, Cumpston AM, Goldsmith WT, McKinney W, Fedan JS, Battelli LA, Munro T, Bucklew-Moyers W, McKinstry K, Schwegler-Berry D, Friend S, Knepp AK, Smith SL, Sriram K.

Am J Pathol. 2016 Nov;186(11):2887-2908. doi: 10.1016/j.ajpath.2016.07.018.

PMID:
27643531
14.

Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time.

Hartwig MG, Ganapathi AM, Osho AA, Hirji SA, Englum BR, Speicher PJ, Palmer SM, Davis RD, Snyder LD.

Am J Transplant. 2016 Nov;16(11):3270-3277. doi: 10.1111/ajt.13892. Epub 2016 Jul 15.

PMID:
27233085
15.

Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation.

Vock DM, Durheim MT, Tsuang WM, Finlen Copeland CA, Tsiatis AA, Davidian M, Neely ML, Lederer DJ, Palmer SM.

Ann Am Thorac Soc. 2017 Feb;14(2):172-181. doi: 10.1513/AnnalsATS.201606-507OC.

PMID:
27779905
16.

Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.

DerHovanessian A, Todd JL, Zhang A, Li N, Mayalall A, Finlen Copeland CA, Shino M, Pavlisko EN, Wallace WD, Gregson A, Ross DJ, Saggar R, Lynch JP 3rd, Belperio J, Snyder LD, Palmer SM, Weigt SS.

Ann Am Thorac Soc. 2016 May;13(5):627-35. doi: 10.1513/AnnalsATS.201510-719OC.

17.

The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.

Diamond JM, Porteous MK, Roberts LJ 2nd, Wickersham N, Rushefski M, Kawut SM, Shah RJ, Cantu E 3rd, Lederer DJ, Chatterjee S, Lama VN, Bhorade S, Crespo M, McDyer J, Wille K, Orens J, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Hage C, Palmer SM, Snyder L, Calfee CS, Ware LB, Christie JD; Lung Transplant Outcomes Group.

J Heart Lung Transplant. 2016 Apr;35(4):500-507. doi: 10.1016/j.healun.2015.12.012. Epub 2016 Jan 7.

18.

Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.

O'Brien EC, Durheim MT, Gamerman V, Garfinkel S, Anstrom KJ, Palmer SM, Conoscenti CS.

BMJ Open Respir Res. 2016 Jan 11;3(1):e000108. doi: 10.1136/bmjresp-2015-000108. eCollection 2016.

19.

Reduced Cerebral Perfusion Pressure during Lung Transplant Surgery Is Associated with Risk, Duration, and Severity of Postoperative Delirium.

Smith PJ, Blumenthal JA, Hoffman BM, Rivelli SK, Palmer SM, Davis RD, Mathew JP.

Ann Am Thorac Soc. 2016 Feb;13(2):180-7. doi: 10.1513/AnnalsATS.201507-454OC.

20.

Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.

Cantu E, Suzuki Y, Diamond JM, Ellis J, Tiwari J, Beduhn B, Nellen JR, Shah R, Meyer NJ, Lederer DJ, Kawut SM, Palmer SM, Snyder LD, Hartwig MG, Lama VN, Bhorade S, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Wilkes D, Roe D, Ware LB, Wang F, Feng R, Christie JD; Lung Transplant Outcomes Group.

Am J Transplant. 2016 Mar;16(3):833-40. doi: 10.1111/ajt.13525. Epub 2015 Dec 10.

Supplemental Content

Loading ...
Support Center